eur, page-253

Probably the only thing we have in common is that we own shares in Sages's CLE, now selling at $0.001.

I think there are many posters here who look very challenged. Why their inability to avoid personalising and insulting anybody who posts here with views that doubt EUR's success.

I see no chance that Tanbreez will go from laboratory size to a scaled testing and to a pilot plant. If I am right, how would EUR get its money back?

Sage has reduced EUR's cash and cash equivalents at end of the last quarter to $9,571 from $13,145. Buying Tanbreez's unlisted shares was no trivial matter for EUR financially.

As I said, what we have in common are shares in Sage's hopeless CLE.